Boekhorst Paul Francis Olivier Te - 29 Oct 2025 Form 3 Insider Report for IMMUCELL CORP /DE/ (ICCC)

Role
President and CEO, Director
Signature
/s/ Timothy C. Fiori Attorney-in-Fact
Issuer symbol
ICCC
Transactions as of
29 Oct 2025
Net transactions value
$0
Form type
3
Filing time
07 Nov 2025, 07:41:07 UTC
Next filing
12 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
te Boekhorst Paul Francis Olivier President and CEO, Director C/O IMMUCELL CORPORATION, 56 EVERGREEN DRIVE, PORTLAND /s/ Timothy C. Fiori Attorney-in-Fact 07 Nov 2025 0002095704

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ICCC Non Qualified Stock Option (right to buy) 29 Oct 2025 Common Stock 25,327 $5.90 Direct
holding ICCC Non Qualified Stock Option (right to buy) 29 Oct 2025 Common Stock 25,327 $5.90 Direct
holding ICCC Non Qualified Stock Option (right to buy) 29 Oct 2025 Common Stock 25,329 $5.90 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Option grant made to Mr. te Boekhorst at the time he and the Issuer entered into an offer letter outlining the tentative terms of his employment as President and CEO. Option granted as a nonqualified stock option within the meaning of the Internal Revenue Code. Option vests in 3 increments as shown in the foregoing table.